NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Scientific Evaluation of One or Two Doses of a Vaccine Against Human Papillomavirus: Long Term Follow Up of Gardasil9 Recipients in the ESCUDDO Study ("Estudio de Comparación de Una y Dos Dosis de Vacunas Contra el Virus de Papiloma Humano [VPH]")

NCT07706673

Not Yet RecruitingN/A

Sponsor: National Cancer Institute (NCI)

Conditions: Human Papillomavirus-Related Malignant Neoplasm

Interventions: Non-Interventional Study

Countries: Costa Rica

This study evaluates the long term protection provided by either one or two doses of the HPV vaccine for patients who were part of the ESCUDDO study.

Eligibility overview

Sex: FEMALE

Age: 12 Years to —

Healthy volunteers: Yes

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* \* Participation in ESCUDDO base study

  * Randomization (excluding the two participants who had major protocol deviations in the ESCUDDO base study) to the Gardasil9 1- and 2-dose arms
  * A signed informed consent form for ESCUDDO LTFU.
  * Opportunity to complete three total study visits

Exclusion Criteria:

* \* Enrollment cannot occur beyond her 10 year study visit

Locations (1)

Liberia, Guanacaste Province, Costa Rica